​

Shattuck Labs (STTK) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Shattuck Labs Revenue Highlights

Latest Revenue (Y)

$5.72M

Latest Revenue (Q)

$1.61M

Main Segment (Y)

License

Shattuck Labs Revenue by Period

Shattuck Labs Revenue by Year

DateRevenueChange
2024-12-31$5.72M245.26%
2023-12-31$1.66M154.14%
2022-12-31$652.00K-97.83%
2021-12-31$30.02M202.16%
2020-12-31$9.93M0.48%
2019-12-31$9.89M-55.94%
2018-12-31$22.44M-

Shattuck Labs generated $5.72M in revenue during NA 2024, up 245.26% compared to the previous quarter, and up 57.86% compared to the same period a year ago.

Shattuck Labs Revenue by Quarter

DateRevenueChange
2024-06-30$1.61M44.30%
2024-03-31$1.11M56.16%
2023-12-31$714.00K4.08%
2023-09-30$686.00K243.00%
2023-06-30$200.00K250.88%
2023-03-31$57.00K-85.38%
2022-12-31$390.00K83.96%
2022-09-30$212.00K324.00%
2022-06-30$50.00K100.00%
2022-03-31--100.00%
2021-12-31$30.08M1483.05%
2021-09-30$1.90M-144.91%
2021-06-30$-4.23M-286.39%
2021-03-31$2.27M69.15%
2020-12-31$1.34M-44.89%
2020-09-30$2.44M-23.45%
2020-06-30$3.18M6.89%
2020-03-31$2.98M5.49%
2019-12-31$2.82M58.13%
2019-09-30$1.78M-

Shattuck Labs generated $1.61M in revenue during Q2 2024, up 44.30% compared to the previous quarter, and up 2822.81% compared to the same period a year ago.

Shattuck Labs Revenue Breakdown

Shattuck Labs Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
License$3.40M

Shattuck Labs's latest annual revenue breakdown by segment (product or service), as of Dec 24: License (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24Mar 24
License-$3.00M$1.50M$800.00K

Shattuck Labs Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLUEMonte Rosa Therapeutics$75.62M$4.70M
NRIXNurix Therapeutics$54.55M$18.45M
KYMRKymera Therapeutics$47.07M$3.74M
STOKStoke Therapeutics$36.55M$4.89M
FHTXFoghorn Therapeutics$22.60M$7.81M
CCCCC4 Therapeutics$20.76M-
IPSCCentury Therapeutics$6.59M$791.00K
STTKShattuck Labs$5.72M$1.61M
PRLDPrelude Therapeutics--
PMVPPMV Pharmaceuticals--
CSBRChampions Oncology--

STTK Revenue FAQ

What is Shattuck Labs’s yearly revenue?

Shattuck Labs's yearly revenue for 2024 was $5.72M, representing an increase of 245.26% compared to 2023. The company's yearly revenue for 2023 was $1.66M, representing an increase of 154.14% compared to 2022. STTK's yearly revenue for 2022 was $652K, representing a decrease of -97.83% compared to 2021.

What is Shattuck Labs’s quarterly revenue?

Shattuck Labs's quarterly revenue for Q2 2024 was $1.61M, a 44.30% increase from the previous quarter (Q1 2024), and a 704.50% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.12M, a 56.16% increase from the previous quarter (Q4 2023), and a 1856.14% increase year-over-year (Q1 2023). STTK's quarterly revenue for Q4 2023 was $714K, a 4.08% increase from the previous quarter (Q3 2023), and a 83.08% increase year-over-year (Q4 2022).

What is Shattuck Labs’s revenue growth rate?

Shattuck Labs's revenue growth rate for the last 3 years (2022-2024) was 777.45%, and for the last 5 years (2020-2024) was -42.41%.

What are Shattuck Labs’s revenue streams?

Shattuck Labs's revenue streams in c 24 are License

What is Shattuck Labs’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Shattuck Labs was License. This segment made a revenue of $3.4M, representing 100.00% of the company's total revenue.